Related Experiment Video
Updated: Dec 28, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Obesity and cardiovascular disease in women
Camila Manrique-Acevedo1,2,3, Bhavana Chinnakotla1, Jaume Padilla3,4
1Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, USA.
Insights
Obesity increases cardiovascular disease (CVD) risk, especially in women. This review explores how obesity uniquely impacts women
Area of Science:
- Cardiovascular Science
- Endocrinology
- Women's Health
Background:
- Rising global obesity rates contribute to a significant health and financial burden from related comorbidities.
- Cardiovascular disease (CVD) is strongly linked to increased adiposity, with women facing a disproportionately higher risk.
- Obese women, particularly those with insulin resistance, exhibit elevated risks for heart failure with preserved ejection fraction and ischemic heart disease.
Purpose of the Study:
- To review evidence on the differential cardiovascular impact of adiposity in women versus men.
- To explore proposed pathophysiological mechanisms underlying these sex-specific differences.
- To discuss women-specific risk factors for CVD in the context of obesity and insulin resistance.
Main Methods:
- Literature review of existing evidence.
- Analysis of proposed pathophysiological mechanisms.
- Discussion of epidemiological data and clinical observations.
Main Results:
- Obesity presents unique cardiovascular risks for women, differing from those in men.
- Mechanisms include altered aldosterone, mineralocorticoid receptor activation, estrogenic signaling, and androgen levels.
- Women-specific factors like pregnancy weight gain, preeclampsia, gestational diabetes, and menopause exacerbate CVD risk.
Conclusions:
- Understanding sex-specific impacts of obesity on cardiovascular health is crucial.
- Targeted interventions considering women's unique risk factors are needed to combat the CVD epidemic.
- Further research into the mechanisms driving differential CVD risk in obese women is warranted.
Abstract:
As the prevalence of obesity continues to grow worldwide, the health and financial burden of obesity-related comorbidities grows too. Cardiovascular disease (CVD) is clearly associated with increased adiposity. Importantly, women are at higher risk of CVD when obese and insulin resistant, in particular at higher risk of developing heart failure with preserved ejection fraction and ischemic heart disease. Increased aldosterone and mineralocorticoid receptor activation, aberrant estrogenic signaling and elevated levels of androgens are among some of the proposed mechanisms explaining the heightened CVD risk. In addition to traditional cardiovascular risk factors, understanding nontraditional risk factors specific to women, like excess weight gain during pregnancy, preeclampsia, gestational diabetes, and menopause are central to designing personalized interventions aimed to curb the epidemic of CVD. In the present review, we examine the available evidence supporting a differential cardiovascular impact of increased adiposity in women compared with men and the proposed pathophysiological mechanisms behind these differences. We also discuss women-specific cardiovascular risk factors associated with obesity and insulin resistance.
More Related Videos
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Related Concept Videos
Obesity
Coronary Artery Disease I: Introduction
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion